Close X
Friday, November 15, 2024
ADVT 
International

US Mission in India processes over 1 mn non-immigrant visas in 2023

Darpan News Desk IANS, 28 Sep, 2023 10:48 AM
  • US Mission in India processes over 1 mn non-immigrant visas in 2023

New Delhi, Sep 28 (IANS): The US Mission to India said on Thursday that it has reached and surpassed its goal to process one million non-immigrant visa applications in 2023.

Stating that Indians made over one in 10 visa applications worldwide, the Mission said it has already surpassed the total number of cases processed in 2022 and is processing almost 20 per cent more applications than in pre-pandemic 2019.

“Our partnership with India is one of the United States’ most important bilateral relationships, and in fact one of the most important relationships in the world," US Ambassador to India Eric Garcetti said.

"The ties between our people are stronger than ever, and we will continue our record-setting volume of visa work in the coming months to give as many Indian applicants as possible the opportunity to travel to the United States and experience the US-India friendship firsthand,” Garcetti added.

The Ambassador on Thursday handed over the passport to the one millionth visa holder and said: “… this year we are so proud… we have processed over 1 million visa applications."

Last year ,over 1.2 million Indians visited the US, making this one of the most robust travel relationships in the world.

Indians now represent over 10 per cent of all visa applicants worldwide, including 20 per cent of all student visa applicants and 65 per cent of all H&L-category (employment) visa applicants.

Recognising the continued high demand for its visas, the Mission said that the US continues to invest heavily in our operations in India.

In the past year, the Mission said it expanded its staffing to facilitate more visa processing, and made significant capital improvements to existing facilities, such as the US Consulate in Chennai, and inaugurating a new Consulate building in Hyderabad.

The Mission said that beginning next year, it plans to implement a pilot program that would allow domestic visa renewal for qualified H&L-category employment visa applicants.

MORE International ARTICLES

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine